Neurophet

Neurophet Inventory

The Inventory of Neurophet (380550.KQ) as of Oct 16, 2026 is 47.24 M KRW. In the previous year, Inventory was 10.86 M KRW — a change of 334.75% (higher).

Inventory

47.24 MKRW

YoY

334.75%

Last updated:

Inventory of Neurophet is 2025 47.24 M KRW. Inventory of Neurophet was 2024 10.86 M KRW. It decreases by 334.75% higher compared to the previous year.

The Neurophet Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2022
212.28 M KRW
Jan 1, 2023
97.12 M KRW
Jan 1, 2024
10.86 M KRW
Jan 1, 2025
47.24 M KRW
The Neurophet Inventory history
YEARInventoryYoY
47.24 MKRW+334.75%
10.86 MKRW-88.81%
97.12 MKRW-54.25%
212.28 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neurophet Stock analysis

What does Neurophet do? Neurophet Inc is a South Korean company operating in the Health Care sector, headquartered in Seoul. The company has 135 employees and is listed on the Korean stock exchange with the ticker 380550.KQ and ISIN KR7380550004. Neurophet Inc went public on July 25, 2025, marking its initial public offering. The company focuses on the research, development, and sales of brain imaging analysis software, including PET image quantitative analysis software called 'Neurophet SCALE PET' and neurodegenerative brain disease diagnosis support software named 'Neurophet AQUA'. Additionally, Neurophet Inc develops and sells therapeutic medical devices and provides medical artificial intelligence solutions. The company's website is https://www.neurophet.com/. Neurophet Inc operates within the Health Care Technology industry, specializing in software and AI-driven tools for medical imaging and diagnostics. The company's products are designed to support healthcare professionals in analyzing brain imaging data and diagnosing neurological conditions. As a technology-focused health care provider, Neurophet Inc aims to enhance diagnostic accuracy and efficiency through its software solutions. The company's operations are based in Seoul, South Korea, and it is engaged in both the development and commercialization of its medical technology products. Neurophet Inc's business model centers on creating innovative software tools that address specific challenges in neurology and brain imaging analysis. Neurophet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurophet stock

Inventory of Neurophet is 47.24 M KRW in 2025.

Inventory of Neurophet changed from 10.86 M KRW to 47.24 M KRW, representing a 334.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Neurophet since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Neurophet historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Neurophet

All Key Metrics — Neurophet